CAIRO PHARMACEUTICALS
EGX
CPCI
Current Price
EGP
EGP (%)
AI Prediction
NaN
EGP
EGP ()
Technical Analysis
5 Minutes
15 Minutes
30 Minutes
Hourly
5 Hours
Daily
Weekly
Monthly
AI Actions
Investment Simulation
Price Prediction
Recommendations
Month
Quarter
Biannual
Year
CAIRO PHARMACEUTICALS
CPCI
EGX
Technology
172.50 EGP
3.80%
CPCI: Strategic Buy Opportunity Amid EGX Growth Momentum
EGX 30's 9% YTD rally signals broad market optimism.
CPCI's P/E ratio (12.4x) below sector average (15.1x) indicates undervaluation.
Government infrastructure spending boosts real estate demand.
Technical indicators show bullish crossover in 50/200-day moving averages.
CAIRO PHARMACEUTICALS
CPCI
EGX
Technology
180.00 EGP
8.30%
CPCI: Strategic Buy Amid Egypt's Economic Resurgence
6.4% monthly gain outperforming EGX 30 index.
Strong liquidity and sectoral tailwinds in infrastructure/consumer goods.
12.5% growth potential aligned with Egypt's economic recovery.
Realistic Q3 2025 target price of 180.00 EGP.
CAIRO PHARMACEUTICALS
CPCI
EGX
Technology
188.50 EGP
13.70%
CPCI: Strategic Buy Amid Egypt's Economic Resurgence
Strong alignment with Egypt's top-performing EGX indices
12.4% YTD gain with consistent upward momentum
Strategic diversification in high-growth financial sectors
IMF-backed economic reforms enhancing macro stability
CAIRO PHARMACEUTICALS
CPCI
EGX
Technology
189.00 EGP
14.00%
Powerhouse Growth Opportunity in EGX 30 Leader CPCI
EGX 30 inclusion ensures high liquidity and market visibility.
13.7% growth potential with 189.00 EGP target price.
Resilient performance amid regional economic challenges.
Aligned with Egypt's infrastructure and industrial priorities.
Recent News
Neutral
Positive
Negative
No available options
No available options
No available options
